FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The Food and Drug Administration on Friday raised concerns about the health effects of MDMA as a treatment for post-traumatic stress disorder, citing flaws in a company’s studies that could pose major obstacles to approval of a treatment anticipated to help people struggling with the condition. The agency said that bias had seeped into the …

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws Read More »